Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
PHASE3
To compare the effect on glycemic control (HbA1c) of exenatide suspension a...
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
PHASE3
Study D5553C00002 is a multicenter, randomized, double-blind, placebo-contr...
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
PHASE2
Obesity is a medical condition which increases the risk of other diseases, ...
Status
Completed
Location
Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
PHASE3
Study D5553C0003 is a 28-week, randomized, double-blind, active-controlled,...